ARHGAP19 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.977400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.754800E-01
Normal-vs-Stage2
3.944000E-01
Normal-vs-Stage3
3.092400E-01
Normal-vs-Stage4
3.870400E-01
Stage1-vs-Stage2
2.802600E-01
Stage1-vs-Stage3
4.351900E-02
Stage1-vs-Stage4
3.798400E-01
Stage2-vs-Stage3
3.964800E-03
Stage2-vs-Stage4
8.742000E-01
Stage3-vs-Stage4
2.021400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.002400E-01
Normal-vs-AfricanAmerican
4.332000E-01
Normal-vs-Asian
3.225400E-01
Caucasian-vs-AfricanAmerican
6.514000E-01
Caucasian-vs-Asian
5.736400E-03
AfricanAmerican-vs-Asian
2.419700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.860000E-01
Normal-vs-Female
4.129200E-01
Male-vs-Female
2.437200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.671800E-01
Normal-vs-Age(41-60Yrs)
4.355600E-01
Normal-vs-Age(61-80Yrs)
3.792800E-01
Normal-vs-Age(81-100Yrs)
3.864200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.635800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.493600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.217000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.140200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.132600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.970400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.874400E-01
Normal-vs-Daily Drinker
3.830200E-01
Normal-vs-Weekly Drinker
3.509400E-01
Normal-vs-Occasional Drinker
3.985600E-01
Normal-vs-Social Drinker
4.502000E-01
Non Drinker-vs-Daily Drinker
9.206400E-01
Non Drinker-vs-Weekly Drinker
4.176000E-01
Non Drinker-vs-Occasional Drinker
8.005000E-01
Non Drinker-vs-Social Drinker
3.657000E-01
Daily Drinker-vs-Weekly Drinker
3.718000E-01
Daily Drinker-vs-Occasional Drinker
6.849800E-01
Daily Drinker-vs-Social Drinker
3.795200E-01
Weekly Drinker-vs-Occasional Drinker
2.401200E-01
Weekly Drinker-vs-Social Drinker
1.809170E-01
Occasional Drinker-vs-Social Drinker
5.227400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.216400E-01
Normal-vs-Grade 2
8.340200E-01
Normal-vs-Grade 3
7.674800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.920600E-01
Grade 1-vs-Grade 3
4.086000E-01
Grade 1-vs-Grade 4
6.216400E-01
Grade 2-vs-Grade 3
2.596600E-01
Grade 2-vs-Grade 4
8.340200E-01
Grade 3-vs-Grade 4
7.674800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.920600E-01
Normal-vs-NonDiabetic
3.857400E-01
Diabetic-vs-NonDiabetic
8.253200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.401000E-01
Normal-vs-NoPancreatitis
3.878400E-01
Pancreatitis-vs-NoPancreatitis
2.955600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.211600E-01
Normal-vs-N1
3.905200E-01
N0-vs-N1
2.530600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.810200E-01
Normal-vs-TP53-NonMutant
4.591400E-01
TP53-Mutant-vs-TP53-NonMutant
2.488000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
